In silico study of the active compounds in bitter melon (Momordica charantia L) as antidiabetic medication
Antidiabetic are many drugs available in the market, but most medications have side effects that are relatively high and cause toxicity, so it needs tobe develoved search of new drug compounds were more potent drugs with side effects as low. Various research have shown that bitter melon (Momordica c...
Saved in:
Main Authors: | Ruswanto Ruswanto (Author), Richa Mardianingrum (Author), Tresna Lestari (Author), Tita Nofianti (Author), Lilis Tuslinah (Author), Dudi Nurmalik (Author) |
---|---|
Format: | Book |
Published: |
Universitas Ahmad Dahlan,
2018-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
<it>Momordica charantia </it>(bitter melon) inhibits primary human adipocyte differentiation by modulating adipogenic genes
by: Nerurkar Vivek R, et al.
Published: (2010) -
Effects of Karela (Bitter Melon; Momordica charantia) on genes of lipids and carbohydrates metabolism in experimental hypercholesterolemia: biochemical, molecular and histopathological study
by: Dalia Yossri Saad, et al.
Published: (2017) -
Investigation of genes coding for anti-HIV proteins MAP30 and MRK29 from Thai bitter melon (Momordica charantia L.)
by: Paktraporn Mekloy, et al.
Published: (2022) -
Total phenol, flavonoid, and anthocyanin content and antioxidant activity of Etlingera elatior extract and nanoparticle
by: Tresna Lestari, et al.
Published: (2018) -
Effect Administration of Ethanol Extract of Bitter Melon (Momordica Charantia L.) On The Reduction of MDA (Malondialdehyde) Levels Serum in Rats Given a High-Fat Diet
by: Andiani Andiani, et al.
Published: (2018)